Info
- Utilizzare la checkbox di selezione a fianco di ciascun documento per attivare le funzionalità di stampa, invio email, download nei formati disponibili del (i) record.
The competitive status of the U.S. pharmaceutical industry : the influences of technology in determining international industrial competitive advantage / / prepared by the Pharmaceutical Panel Committee on Technology and International Economic and Trade Issues, Office of the Foreign Secretary National Academy of Engineering, Commission on Engineering and Technical Systems National Research Council ; Charles C. Edwards, chairman ; Lacy Glenn Thomas, rapporteur
| The competitive status of the U.S. pharmaceutical industry : the influences of technology in determining international industrial competitive advantage / / prepared by the Pharmaceutical Panel Committee on Technology and International Economic and Trade Issues, Office of the Foreign Secretary National Academy of Engineering, Commission on Engineering and Technical Systems National Research Council ; Charles C. Edwards, chairman ; Lacy Glenn Thomas, rapporteur |
| Edizione | [1st ed.] |
| Pubbl/distr/stampa | Washington, D.C. ; ; [Great Britain], : National Academy Press, 1983 |
| Descrizione fisica | 1 online resource (114 p.) |
| Disciplina | 338.4761510973 |
| Altri autori (Persone) | EdwardsCharles C |
| Soggetto topico |
Pharmaceutical industry - Technological innovations - United States
Pharmaceutical industry - United States Competition - United States Drugs - United States - Marketing |
| ISBN |
1-280-24696-0
9786610246960 0-309-57203-7 0-585-21783-1 |
| Formato | Materiale a stampa  |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
The Competitive Status of the U.S. Pharmaceutical Industry -- Copyright -- Preface -- Contents -- Summary -- FINDINGS ON THE U.S. COMPETITIVE POSITION -- DETERMINANTS OF NATIONAL PHARMACEUTICAL COMPETITIVE ADVANTAGE -- OPTIONS FOR AMERICAN POLICY -- Trade Options -- Domestic Economic Options -- Regulatory Options -- 1 Overview of U.S. Pharmaceutical Industry -- EMERGENCE OF THE MODERN PHARMACEUTICAL INDUSTRY -- NATURE OF PHARMACEUTICAL COMPETITION -- BENEFITS AND RISKS OF TECHNICAL CHANGE -- OVERVIEW AND LIMITATIONS OF THIS STUDY -- NOTES -- 2 Competitive Position of the U.S. Pharmaceutical Industry -- RESEARCH -- INNOVATION -- PRODUCTION -- SALES -- STRUCTURE -- TRADE -- SUMMARY -- NOTES -- 3 Determinants of National Pharmaceutical Competitive Advantage -- LABOR COSTS -- MARKET GROWTH -- NATIONAL SCIENTIFIC CAPACITY -- GENERAL RELATIVE DECLINE OF U.S. INDUSTRY -- INDUSTRIAL POLICY: REGULATION -- Greater Use of Expert Committees -- Greater Acceptance of Foreign Data -- Less Politicization of Drug Approval Process -- Greater Cooperation between Regulators and Industry -- INDUSTRIAL POLICY: TAXATION -- INDUSTRIAL POLICY: TRADE -- SUMMARY -- NOTES -- 4 New Developments Affecting the Industry -- SCIENTIFIC ADVANCES -- JAPANESE DEVELOPMENTS -- NOTES -- 5 Options for American Industrial Policy -- TRADE OPTIONS -- DOMESTIC ECONOMIC OPTIONS -- REGULATORY OPTIONS -- The IND Process -- Early Clinical Research -- Objectives of Investigational Drug Regulation -- Clinical Development Studies -- Preclearance of Clinical Research -- The NDA Process -- Application of the Standards for Drug Approval -- The NDA Submission and Its Review -- Utilization of Outside Expert Advice -- Application of the Standards for Drug Approval -- FDA Management -- Resources for the New Drug Review Process -- Improving Interactions with Industry.
Tracking the Review Process to Ensure Timeliness -- Conflict of Interest and Expert Advisers -- Improving Interactions with Industry -- NOTES -- 6 Biographical Sketches -- Index. |
| Record Nr. | UNINA-9910817036303321 |
| Washington, D.C. ; ; [Great Britain], : National Academy Press, 1983 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Direct-to-consumer advertising [[electronic resource] ] : marketing, education, or deception? : hearing before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundred Tenth Congress, second session, May 8, 2008
| Direct-to-consumer advertising [[electronic resource] ] : marketing, education, or deception? : hearing before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundred Tenth Congress, second session, May 8, 2008 |
| Pubbl/distr/stampa | Washington : , : U.S. G.P.O., , 2009 |
| Descrizione fisica | 1 online resource (iii, 548 pages) : illustrations |
| Soggetto topico |
Direct-to-consumer prescription drug advertising - United States
Advertising - Drugs - United States Drugs - United States - Marketing Prescription pricing - United States |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Altri titoli varianti | Direct-to-consumer advertising |
| Record Nr. | UNINA-9910697091203321 |
| Washington : , : U.S. G.P.O., , 2009 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
The Express Scripts/Medco merger [[electronic resource] ] : cost savings for consumers or more profits for the middlemen? : hearing before the Subcommittee on Antitrust, Competition Policy and Consumer Rights of the Committee on the Judiciary, United States Senate, One Hundred Twelfth Congress, first session, December 6, 2011
| The Express Scripts/Medco merger [[electronic resource] ] : cost savings for consumers or more profits for the middlemen? : hearing before the Subcommittee on Antitrust, Competition Policy and Consumer Rights of the Committee on the Judiciary, United States Senate, One Hundred Twelfth Congress, first session, December 6, 2011 |
| Pubbl/distr/stampa | Washington : , : U.S. G.P.O., , 2012 |
| Descrizione fisica | 1 online resource (iv, 411 pages) : illustrations |
| Collana | S. hrg. |
| Soggetto topico |
Pharmaceutical industry - Mergers - United States
Pharmaceutical services insurance - United States - Management Drugs - United States - Marketing Mail-order business - United States - Management Health services administration - United States Consolidation and merger of corporations - United States |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Altri titoli varianti | Express Scripts/Medco merger |
| Record Nr. | UNINA-9910701783003321 |
| Washington : , : U.S. G.P.O., , 2012 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
FDA user fees 2012 : issues related to accelerated approval, medical gas, antibiotic development, and downstream pharmaceutical supply chain : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Twelfth Congress, second session, March 8, 2012
| FDA user fees 2012 : issues related to accelerated approval, medical gas, antibiotic development, and downstream pharmaceutical supply chain : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Twelfth Congress, second session, March 8, 2012 |
| Pubbl/distr/stampa | Washington : , : U.S. Government Printing Office, , 2013 |
| Descrizione fisica | 1 online resource (iv, 214 pages) : illustrations |
| Soggetto topico |
Drug approval - United States
Gases - Therapeutic use - Government policy - United States Antibiotics - Development - United States Drugs - United States - Marketing |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Altri titoli varianti | FDA user fees 2012 |
| Record Nr. | UNINA-9910704708903321 |
| Washington : , : U.S. Government Printing Office, , 2013 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Fueling an epidemic, report four : inside the Insys strategy for boosting fentanyl sales / / U.S. Senate Homeland Security & Governmental Affairs Committee, Ranking Member's Office
| Fueling an epidemic, report four : inside the Insys strategy for boosting fentanyl sales / / U.S. Senate Homeland Security & Governmental Affairs Committee, Ranking Member's Office |
| Pubbl/distr/stampa | [Washington, D.C.] : , : Committee on Homeland Security and Governmental Affairs, , [2018] |
| Descrizione fisica | 1 online resource (35 pages, 159 unnumbered pages) : color illustrations |
| Soggetto topico |
Fentanyl - United States
Opioid abuse - United States Fentanyl - Overdose - United States Drugs - United States - Marketing Pharmaceutical industry - Corrupt practices - United States |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Altri titoli varianti | Fueling an epidemic, report four |
| Record Nr. | UNINA-9910711414403321 |
| [Washington, D.C.] : , : Committee on Homeland Security and Governmental Affairs, , [2018] | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Fueling an epidemic, report two : exposing the financial ties between opoid manufacturers and third party advocacy groups / / U.S. Senate Homeland Security & Governmental Affairs Committee, Ranking Member's Office
| Fueling an epidemic, report two : exposing the financial ties between opoid manufacturers and third party advocacy groups / / U.S. Senate Homeland Security & Governmental Affairs Committee, Ranking Member's Office |
| Pubbl/distr/stampa | [Washington, D.C.] : , : [Committee on Homeland Security and Governmental Affairs], , [2018] |
| Descrizione fisica | 1 online resource (35 pages) : color illustrations |
| Soggetto topico |
Opioid abuse - United States
Pharmaceutical industry - Corrupt practices - United States Pressure groups - United States Drugs - United States - Marketing |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Altri titoli varianti | Fueling an epidemic, report two |
| Record Nr. | UNINA-9910711414303321 |
| [Washington, D.C.] : , : [Committee on Homeland Security and Governmental Affairs], , [2018] | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Postmarketing studies of prescription drugs
| Postmarketing studies of prescription drugs |
| Pubbl/distr/stampa | [Washington, D.C.] : , : Department of Health and Human Services, Office of Inspector General, , 1996 |
| Descrizione fisica | 1 online resource (25 unnumbered pages) : illustration |
| Soggetto topico |
Medicare - Subsidies
Drugs - United States - Marketing |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Record Nr. | UNINA-9910707392903321 |
| [Washington, D.C.] : , : Department of Health and Human Services, Office of Inspector General, , 1996 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Potential effects of a ban on direct-to-consumer advertising of new prescription drugs [[electronic resource]]
| Potential effects of a ban on direct-to-consumer advertising of new prescription drugs [[electronic resource]] |
| Autore | Campbell Sheila (Sheila Marie) |
| Pubbl/distr/stampa | [Washington, D.C.] : , : Congressional Budget Office, , [2011] |
| Descrizione fisica | 1 online resource (8 pages) : illustrations |
| Collana | Economic and budget issue brief |
| Soggetto topico |
Advertising - Drugs - United States
Drugs - United States - Marketing Prescription pricing - United States |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Record Nr. | UNINA-9910703131903321 |
Campbell Sheila (Sheila Marie)
|
||
| [Washington, D.C.] : , : Congressional Budget Office, , [2011] | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Promotion of prescription drugs through payments and gifts
| Promotion of prescription drugs through payments and gifts |
| Pubbl/distr/stampa | [Washington, D.C.] : , : Department of Health and Human Services, Office of Inspector General, , [1991] |
| Descrizione fisica | 1 online resource (43 unnumbered pages) : illustrations |
| Soggetto topico |
Drugs - United States - Marketing
Sales promotion - United States Physicians - United States - Finance, Personal Business ethics - United States Corporations - Corrupt practices - United States |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Record Nr. | UNINA-9910707357703321 |
| [Washington, D.C.] : , : Department of Health and Human Services, Office of Inspector General, , [1991] | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
The proposed merger between Express Scripts and Medco [[electronic resource] ] : hearing before the Subcommittee on Intellectual Property, Competition, and the Internet of the Committee on the Judiciary, House of Representatives, One Hundred Twelfth Congress, first session, September 20, 2011
| The proposed merger between Express Scripts and Medco [[electronic resource] ] : hearing before the Subcommittee on Intellectual Property, Competition, and the Internet of the Committee on the Judiciary, House of Representatives, One Hundred Twelfth Congress, first session, September 20, 2011 |
| Pubbl/distr/stampa | Washington : , : U.S. G.P.O., , 2011 |
| Descrizione fisica | 1 online resource (iv, 141 pages) : illustrations |
| Soggetto topico |
Pharmaceutical industry - Mergers - United States
Pharmaceutical services insurance - United States - Management Drugs - United States - Marketing Mail-order business - United States - Management Health services administration - United States Consolidation and merger of corporations - United States |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Altri titoli varianti | Proposed merger between Express Scripts and Medco |
| Record Nr. | UNINA-9910703210103321 |
| Washington : , : U.S. G.P.O., , 2011 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
